Miao, Ruoyu
Swank, Jennifer
Melzer, Dan
Ludlow, Steven
Clark, Leah
Finger, Molly
Reed, Damon R.
Druta, Mihaela
Brohl, Andrew S.
Article History
Received: 27 December 2022
Accepted: 25 January 2023
First Online: 13 March 2023
Declarations
:
: DM: speakers bureau: Jazz Pharmaceuticals; advisory board: Pfizer, Eli Lilly, and Takeda Pharmaceuticals; consultant: Dedham Group. JS: consultant: Iovance. DRR: advisory board: Springworks and Eisai. ASB: advisory board: Bayer and Deciphera. All stated disclosures are outside the scope current work. All other authors report no financial disclosures.
: This study was reviewed and approved by the Institutional Review Board at MCC. The authors consent for publication.